Advertisement
U.S. markets open in 7 hours 8 minutes
Advertisement

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
28.63-0.16 (-0.56%)
At close: 04:00PM EST
28.62 -0.00 (-0.02%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close28.79
Open28.82
Bid0.00 x 900
Ask0.00 x 1400
Day's Range28.50 - 28.90
52 Week Range28.30 - 54.93
Volume35,171,817
Avg. Volume31,396,747
Market Cap161.657B
Beta (5Y Monthly)0.56
PE Ratio (TTM)15.64
EPS (TTM)1.83
Earnings DateJan 29, 2024 - Feb 02, 2024
Forward Dividend & Yield1.64 (5.73%)
Ex-Dividend DateNov 09, 2023
1y Target Est40.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
8% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PFE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Pfizer, Inc.
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more